Gazette Tracker
Gazette Tracker

Core Purpose

Corrigendum issued by the National Pharmaceutical Pricing Authority correcting entries in notification S.O. 5493(E) dated 19th December 2024 regarding retail price fixation.

Detailed Summary

The National Pharmaceutical Pricing Authority, under the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, issued Corrigendum S.O. 2025(E) on 6th May 2025. This corrigendum amends their previous notification S.O. 5493(E), dated 19th December 2024, which related to the fixation of retail prices and was published in the Gazette of India, Extraordinary. Specifically, the entries at Serial Numbers 13 and 14 of the Table in the said notification are corrected. For Serial Number 13, concerning Cholecalciferol (Vitamin D3) oral solution (60000IU in nano droplet form per 5ml) manufactured/marketed by M/s Ravenbhel Healthcare Pvt. Ltd./M/s Aristo Laboratories Pvt. Ltd., the retail price is corrected from Rs. 18.93 to Rs. 14.26 per ML. For Serial Number 14, an entry is added/corrected for Cholecalciferol (Vitamin D3) oral solution (60000IU per 5ml) manufactured/marketed by M/s Ravenbhel Healthcare Pvt. Ltd./M/s Macleods Pharmaceuticals Ltd., with a retail price of Rs. 14.26 per ML. All other notes and contents mentioned in the original order S.O. 5493(E), dated 19th December 2024, remain unchanged.

Full Text

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-06052025-262932 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 1981] NEW DELHI, TUESDAY, MAY 6, 2025/VAISAKHA 16, 1947 2979 GI/2025 MINISTRY OF CHEMICALS AND FERTILIZERS Department of Pharmaceuticals National Pharmaceutical Pricing Authority CORRIGENDUM New Delhi, the 6 May 2025 S.O. 2025(E). In the National Pharmaceutical Pricing Authority's notification S.O. 5493(E), dated 19th December 2024 relating to fixation of retail price, published in the Gazette of India, Extraordinary, the Entry at Sl. No. 13 & 14 of the Table, both in Hindi & English version shall henceforth: Instead of +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ | S. | Medicines | Strength | Unit | Manufacturer & Marketing | Retail Price | | No. | | | | Company | (Rs.) | +=====+=============================+============================+======+=================================+============+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ | 13 | Cholecalciferol | Each 5 ml contains: | 1 | M/s Ravenbhel Healthcare Pvt. | 18.93 | | | (Vitamin D3) | Cholecalciferol IP (in nano| ML | Ltd./M/s Aristo Laboratories | | | | oral solution | droplet form) 60000IU | | Pvt. Ltd. | | +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ To be read as follows: +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ | S. | Medicines | Strength | Unit | Manufacturer & Marketing | Retail Price | | No. | | | | Company | (Rs.) | +=====+=============================+============================+======+=================================+============+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ | 13 | Cholecalciferol | Each 5 ml contains: | 1 | M/s Ravenbhel Healthcare Pvt. | 14.26 | | | (Vitamin D3) oral | Cholecalciferol IP (in nano| ML | Ltd./M/s Aristo Laboratories | | | | solution | droplet form) 60000IU | | Pvt. Ltd. | | +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ | 14 | Cholecalciferol | Each 5 ml contains: | 1 | M/s Ravenbhel Healthcare Pvt. | 14.26 | | | (Vitamin D3) oral | Cholecalciferol IP | ML | Ltd./M/s Macleods | | | | solution | 60000IU | | Pharmaceuticals Ltd. | | +-----+-----------------------------+----------------------------+------+---------------------------------+------------+ All the notes and other contents mentioned in the original order S.O. 5493(E), dated 19th December 2024 shall remain the same. [F. No. 8(132)/2025/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free